Annual Accounts Payable
$2.35 M
-$1.15 M-32.82%
31 December 2023
Summary:
Mereo BioPharma annual accounts payable is currently $2.35 million, with the most recent change of -$1.15 million (-32.82%) on 31 December 2023. During the last 3 years, it has fallen by -$1.97 million (-45.61%). MREO annual accounts payable is now -70.90% below its all-time high of $8.06 million, reached on 31 December 2019.MREO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.75 M
-$952.00 K-35.26%
30 September 2024
Summary:
Mereo BioPharma quarterly accounts payable is currently $1.75 million, with the most recent change of -$952.00 thousand (-35.26%) on 30 September 2024. MREO quarterly accounts payable is now -88.74% below its all-time high of $15.52 million, reached on 30 June 2017.MREO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | - |
| 3 y3 years | -45.6% | -42.3% |
| 5 y5 years | -57.9% | -79.6% |
MREO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.6% | at low | -49.9% | at low |
| 5 y | 5 years | -70.9% | at low | -79.6% | at low |
| alltime | all time | -70.9% | +91.1% | -88.7% | +42.4% |
Mereo BioPharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.75 M(-35.3%) |
| June 2024 | - | $2.70 M(+10.0%) |
| Mar 2024 | - | $2.46 M(+4.6%) |
| Dec 2023 | $2.35 M(-32.8%) | $2.35 M(-2.7%) |
| June 2023 | - | $2.41 M(-31.0%) |
| Dec 2022 | $3.49 M(+13.2%) | $3.49 M(+2.1%) |
| June 2022 | - | $3.42 M(+11.0%) |
| Dec 2021 | $3.08 M(-28.5%) | $3.08 M(+1.9%) |
| June 2021 | - | $3.03 M(-29.8%) |
| Dec 2020 | $4.31 M | $4.31 M(-36.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $6.76 M(-16.2%) |
| Dec 2019 | $8.06 M(+44.6%) | $8.06 M(-5.9%) |
| June 2019 | - | $8.56 M(+53.6%) |
| Dec 2018 | $5.57 M(+44.2%) | $5.57 M(-14.4%) |
| June 2018 | - | $6.52 M(+68.6%) |
| Dec 2017 | $3.87 M(+214.9%) | $3.87 M(-75.1%) |
| June 2017 | - | $15.52 M(+1164.4%) |
| Dec 2016 | $1.23 M(-34.4%) | $1.23 M(-84.2%) |
| June 2016 | - | $7.76 M(+314.6%) |
| Dec 2015 | $1.87 M | $1.87 M |
FAQ
- What is Mereo BioPharma annual accounts payable?
- What is the all time high annual accounts payable for Mereo BioPharma?
- What is Mereo BioPharma annual accounts payable year-on-year change?
- What is Mereo BioPharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Mereo BioPharma?
What is Mereo BioPharma annual accounts payable?
The current annual accounts payable of MREO is $2.35 M
What is the all time high annual accounts payable for Mereo BioPharma?
Mereo BioPharma all-time high annual accounts payable is $8.06 M
What is Mereo BioPharma annual accounts payable year-on-year change?
Over the past year, MREO annual accounts payable has changed by -$1.15 M (-32.82%)
What is Mereo BioPharma quarterly accounts payable?
The current quarterly accounts payable of MREO is $1.75 M
What is the all time high quarterly accounts payable for Mereo BioPharma?
Mereo BioPharma all-time high quarterly accounts payable is $15.52 M